We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Rejects Roche’s Perjeta, Citing Lack of Evidence
NICE Rejects Roche’s Perjeta, Citing Lack of Evidence
The UK’s National Institute for Health and Care Excellence says it will not recommend Roche’s Perjeta, raising concerns about the lack of evidence backing the drug’s long-term benefits.